Compare ELTX & TII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELTX | TII |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | Canada |
| Employees | N/A | 167 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.4M | 198.5M |
| IPO Year | 2014 | N/A |
| Metric | ELTX | TII |
|---|---|---|
| Price | $2.89 | $1.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $18.00 | $6.38 |
| AVG Volume (30 Days) | ★ 992.3K | 447.8K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,301,000.00 | N/A |
| Revenue This Year | N/A | $4.20 |
| Revenue Next Year | N/A | $3.46 |
| P/E Ratio | ★ N/A | $25.66 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.66 | $1.81 |
| 52 Week High | $16.00 | $5.65 |
| Indicator | ELTX | TII |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 37.79 |
| Support Level | $2.72 | $1.89 |
| Resistance Level | $5.38 | $2.47 |
| Average True Range (ATR) | 0.24 | 0.13 |
| MACD | 0.22 | -0.02 |
| Stochastic Oscillator | 3.95 | 7.60 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
Titan Mining Corp is a Canadian natural resources company. The company is engaged in the acquisition, exploration, development, and extraction of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States, and Kilbourne Graphite Project. The Company operates one reportable segment, mineral production and exploration in the United States.